| MargheRITA (Remote Intelligence for Therapeutic Adherence) (NCT05260203) | Advice Pharma Group srl | 2022-06-04 |
| Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy (NCT05154474) | Weprom | 2022-06-01 |
| Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB) (NCT05223699) | Magenta Therapeutics, Inc. | 2022-02-14 |
| Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis (NCT04800458) | University Hospital, Bordeaux | 2021-05-19 |
| ATG Plus PTCy vs ATG for CGVHD Prophylaxis (NCT04202835) | McMaster University | 2020-10-14 |
| Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS (NCT04166929) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-01-15 |
| TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) (NCT03959241) | Medical College of Wisconsin | 2019-06-25 |
| Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT (NCT04173533) | University of Birmingham | 2019-06-14 |
| Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy (NCT03674411) | Masonic Cancer Center, University of Minnesota | 2019-01-02 |
| Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders (NCT03314974) | Masonic Cancer Center, University of Minnesota | 2018-03-30 |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression (NCT03480360) | Dartmouth-Hitchcock Medical Center | 2018-03-28 |
| Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia (NCT03431090) | Nationwide Children's Hospital | 2018-03-02 |
| Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents (NCT03387475) | University Hospital, Grenoble | 2018-02-20 |
| StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies (NCT02765997) | Masonic Cancer Center, University of Minnesota | 2017-04-01 |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases (NCT01962636) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) (NCT02345850) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-08-01 |
| Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies (NCT02338479) | Center for International Blood and Marrow Transplant Research | 2015-03-01 |
| Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (NCT02323867) | Children's Hospital of Philadelphia | 2014-10-01 |
| Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) (NCT02208037) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-08-01 |
| Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. (NCT01933035) | Beth Israel Medical Center | 2013-10-01 |
| Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant (NCT01904175) | Duke University | 2013-08-01 |
| Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (NCT01956799) | Fondazione Italiana Sindromi Mielodisplastiche-ETS | 2013-05-01 |
| Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations (NCT01911871) | Assistance Publique - Hôpitaux de Paris | 2012-03-01 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia (NCT01297543) | Cellerant Therapeutics | 2011-03-01 |
| Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) (NCT01422603) | University Hospital Southampton NHS Foundation Trust | 2011-02-01 |
| ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies (NCT01110473) | AbbVie (prior sponsor, Abbott) | 2010-04-01 |
| Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy (NCT00990587) | University Health Network, Toronto | 2009-10-01 |
| Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer (NCT00975975) | Indiana University | 2009-09-01 |
| Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy (NCT00963495) | University Health Network, Toronto | 2009-08-01 |
| Sitagliptin Umbilical Cord Blood Transplant Study (NCT00862719) | Indiana University | 2009-03-01 |
| Decitabine, Cytarabine, GCSF for Refractory AML/MDS (NCT00740181) | Brown University | 2008-08-01 |
| Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia (NCT02007863) | University of Miami | 2008-08-01 |
| Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant (NCT00597714) | David Rizzieri, MD | 2008-02-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study (NCT01095874) | Saint-Louis Hospital, Paris, France | 2008-01-01 |
| A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia (NCT00580242) | Massachusetts General Hospital | 2007-11-01 |
| Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies (NCT00593554) | Sherif S. Farag | 2007-08-07 |
| Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia (NCT00434239) | Peter MacCallum Cancer Centre, Australia | 2007-02-01 |
| A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies (NCT00506402) | CASI pharmaceuticals, Inc. | 2006-11-01 |
| Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants (NCT00606437) | Duke University | 2005-09-01 |
| Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED) (NCT00109538) | Merck Sharp & Dohme LLC | 2005-05-01 |
| Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath (NCT00578942) | David Rizzieri, MD | 2005-05-01 |
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant (NCT00354120) | Gruppo Italiano Trapianto di Midollo Osseo | 2005-03-01 |
| Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies (NCT00513318) | University of California, San Francisco | 2004-08-01 |
| HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies (NCT00145626) | St. Jude Children's Research Hospital | 2004-05-01 |
| Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies (NCT00795132) | University of Utah | 2004-04-01 |
| Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT (NCT00516152) | University of California, San Francisco | 2002-11-01 |
| Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies (NCT00514722) | University of California, San Francisco | 2002-10-01 |
| Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia (NCT00513175) | University of California, San Francisco | 2001-10-01 |
| Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients (NCT00195533) | Wyeth is now a wholly owned subsidiary of Pfizer | 2001-07-01 |
| Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia (NCT00136422) | Dana-Farber Cancer Institute | 2000-01-01 |
| Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders (NCT00511537) | University of California, San Francisco | 1999-01-01 |
| Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes (NCT00899223) | Alliance for Clinical Trials in Oncology | 1996-05-01 |